Function of human cytochrome P450s: Characterization of the orphans

Biochemical and Biophysical Research Communications

Volumn 338, Issue 1, 2005, Pages 465-469

  Guengerich, F Peter ^a   Wu, Zhong Liu ^a   Bartleson, Cheryl J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinogens; Cytochrome P450; Orphans; Xenobiotic metabolism

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 20A1; CYTOCHROME P450 27C1; CYTOCHROME P450 2A7; CYTOCHROME P450 2S1; CYTOCHROME P450 2U1; CYTOCHROME P450 2W1; CYTOCHROME P450 3A43; CYTOCHROME P450 4A22; CYTOCHROME P450 4F11; CYTOCHROME P450 4F22; CYTOCHROME P450 4V2; CYTOCHROME P450 4X1; CYTOCHROME P450 4Z1; FATTY ACID; ICOSANOID; MESSENGER RNA; STEROL; UNCLASSIFIED DRUG; VITAMIN; XENOBIOTIC AGENT;

ARTICLE; DRUG METABOLISM; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME SUBSTRATE; GENOME ANALYSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ANALYSIS; XENOBIOTIC METABOLISM;

EID: 27544495165     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.079     Document Type: Review

References (47)

1. P.R. Ortiz de Montellano Cytochrome P450: Structure, Mechanism, and Biochemistry third ed. 2005 KluwerAcademic/Plenum Publishers New York
2. S.L. Kelly, D.E. Kelly, C.J. Jackson, A.G.S. Warrilow, and D.C. Lamb The diversity and importance of microbial cytochromes P450 P.R. Ortiz de Montellano Cytochrome P450: Structure, Mechanism, and Biochemistry third ed. 2005 Kluwer Academic/Plenum Publishers New York 585 617
3. K.A. Nielsen, and B.L. Møller Cytochrome P450s in plants P.R. Ortiz de Montellano Cytochrome P450: Structure, Mechanism, and Biochemistry third ed. 2005 Kluwer Academic/Plenum Publishers New York 553 583
4. F.P. Guengerich Human cytochrome P450 enzymes P.R. Ortiz de Montellano Cytochrome P450: Structure, Mechanism, and Biochemistry third ed. 2005 Kluwer Academic/Plenum Publishers New York 377 531
5. F.P. Guengerich, C.J. Bartleson, Analysis and characterization of enzymes and nucleic acids, in: A.W. Hayes (Ed.), Principles and Methods of Toxicology, 5th ed., CRC Press, Boca Raton, FL, 2005, in press.
6. W.B. Jakoby Detoxication enzymes W.B. Jakoby Enzymatic Basis of Detoxication vol. 1 1980 Academic Press New York 1 6
7. Y.-F. Ueng, T. Kuwabara, Y.-J. Chun, and F.P. Guengerich Cooperativity in oxidations catalyzed by cytochrome P450 3A4 Biochemistry 36 1997 370 381
8. J. Fishman, H.L. Bradlow, J. Schneider, K.E. Anderson, and A. Kappas Radiometric analysis of biological oxidations in man: sex differences in estradiol metabolism Proc. Natl. Acad Sci. USA 77 1980 4957 4960
9. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines Proc. Natl. Acad Sci. USA 186 1989 7696 7700
10. F.J. Gonzalez, and S. Kimura Study of P450 function using gene knockout and transgenic mice Arch. Biochem. Biophys. 409 2003 153 158
11. C.J. Henderson, D.M. Otto, D. Carrie, M.A. Magnuson, A.W. McLaren, I. Rosewell, and C.R. Wolf Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase J. Biol. Chem. 278 2003 13480 13486
12. J. Gu, Y. Weng, Q.Y. Zhang, H. Cui, M. Behr, L. Wu, W. Yang, L. Zhang, and X. Ding Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase J. Biol. Chem. 278 2003 25895 25901
13. I. Stoilov, A.N. Akarsu, and M. Sarfarazi Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21 Hum. Mol. Genet. 6 1997 641 647
14. D.W. Nebert, and D.W. Russell Clinical importance of the cytochromes P450 Lancet 360 2002 1155 1162
15. F.P. Guengerich, M.V. Martin, P.H. Beaune, P. Kremers, T. Wolff, and D.J. Waxman Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism J. Biol. Chem. 261 1986 5051 5060
16. J.A. Krauser, and F.P. Guengerich Cytochrome P450 3A4-catalyzed testosterone 6 β-hydroxylation: stereochemistry, kinetic deuterium isotope effects, and rate-limiting steps J. Biol. Chem. 280 2005 19496 19506
17. D.L. Kroetz, and F. Xu Regulation and inhibition of arachidonic acid (omega)-hydroxylases and 20-HETE formation Annu. Rev. Pharmacol. Toxicol. 45 2005 413 438
18. K. Toide, H. Yamazaki, R. Nagashima, K. Itoh, S. Iwano, Y. Takahashi, S. Watanabe, and T. Kamataki Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells: trimodal distribution of Japanese population according to induction of CYP1B1 mRNA by environmental dioxins Cancer Epidemiol. Biomark. Prev. 12 2003 219 222
19. V. Malaiyandi, E.M. Sellers, and R.F. Tyndale Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence Clin. Pharmacol. Ther. 77 2005 145 158
20. D.J. Mangelsdorf, and R.M. Evans The RXR heterodimers and orphan receptors Cell 83 1995 841 850
21. S. Ding, B.G. Lake, T. Friedberg, and C.R. Wolf Expression and alternative splicing of the cytochrome P-450 CYP2A7 Biochem. J. 306 1995 161 166
22. M. Oscarson, R.A. McLellan, V. Asp, M. Ledesma, M.L. Ruiz, B. Sinues, A. Rautio, and M. Ingelman-Sundberg Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity Hum. Mutat. 20 2002 275 283
23. S.P. Rivera, S.T. Saarikoski, and O. Hankinson Identification of a novel dioxin-inducible cytochrome P450 Mol. Pharmacol. 61 2002 255 259
24. T. Rylander, E.P.A. Neve, M. Ingelman-Sundberg, and M. Oscarson Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1) Biochem. Biophys. Res. Commun. 281 2001 529 535
25. S.T. Saarikoski, T. Suitiala, R. Holmila, O. Impivaara, J. Jarvisalo, A. Hirvonen, and K. Husgafvel-Pursiainen Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population Mutat. Res. 554 2004 267 277
26. G. Smith, C.R. Wolf, Y.Y. Deeni, R.S. Dawe, A.T. Evans, M.M. Comrie, J. Ferguson, and S.H. Ibbotson Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases Lancet 361 2003 1336 1343
27. S.L. Wang, X.Y. He, and J.Y. Hong Human cytochrome P450 2s1: lack of activity in the metabolic activation of several cigarette smoke carcinogens and in the metabolism of nicotine Drug. Metab. Dispos. 33 2005 336 340
28. D. Choudhary, I. Jansson, I. Stoilov, M. Sarfarazi, and J.B. Schenkman Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues Arch. Biochem. Biophys. 436 2005 50 61
29. M. Karlgren, M. Backlund, I. Johansson, M. Oscarson, and M. Ingelman-Sundberg Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1 Biochem. Biophys. Res. Commun. 315 2004 679 685
30. S.S. Chuang, C. Helvig, M. Taimi, H.A. Ramshaw, A.H. Collop, M. Amad, J.A. White, M. Petkovich, G. Jones, and B. Korczak CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes ω- and (ω-1)- hydroxylation of fatty acids J. Biol. Chem. 279 2004 6305 6314
31. T.L. Domanski, C. Finta, J.R. Halpert, and P.G. Zaphiropoulos cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450 Mol. Pharmacol. 59 2001 386 392
32. C. Zeigler-Johnson, T. Friebel, A.H. Walker, Y. Wang, E. Spangler, S. Panossian, M. Patacsil, R. Aplenc, A.J. Wein, S.B. Malkowicz, and T.R. Rebbeck CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer Cancer Res. 64 2004 8461 8467
33. C. Cauffiez, J.M. Lo-Guidice, D. Chevalier, D. Allorge, R. Hamdan, M. Lhermitte, J.J. Lafitte, J.F. Colombel, C. Libersa, and F. Broly First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant Hum. Mutat. 23 2004 101
34. A. Westlind, S. Malmebo, I. Johansson, C. Otter, T.B. Andersson, M. Ingelman-Sundberg, and M. Oscarson Cloning and tissue distribution of a novel human cytochrome P450 of the CYP3A subfamily, CYP3A43 Biochem. Biophys. Res. Commun. 281 2001 1349 1355
35. A. Bellamine, Y. Wang, M.R. Waterman, J.V. Gainer III, E.P. Dawson, N.J. Brown, and J.H. Capdevila Characterization of the CYP4A11 gene, a second CYP4A gene in humans Arch. Biochem. Biophys. 409 2003 221 227
36. U. Savas, M.H. Hsu, and E.F. Johnson Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone Arch. Biochem. Biophys. 409 2003 212 220
37. A. Kalsotra, C.M. Turman, Y. Kikuta, and H.W. Strobel Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids Toxicol. Appl. Pharmacol. 199 2004 295 304
38. A. Li, X. Jiao, F.L. Munier, D.F. Schorderet, W. Yao, F. Iwata, M. Hayakawa, A. Kanai, M. Shy Chen, R. Alan Lewis, J. Heckenlively, R.G. Weleber, E.I. Traboulsi, Q. Zhang, X. Xiao, M. Kaiser-Kupfer, Y.V. Sergeev, and J.F. Hejtmancik Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2 Am. J. Hum. Genet. 74 2004 817 826
39. J. Bylund, C. Zhang, and D.R. Harder Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain Biochem. Biophys. Res. Commun. 296 2002 677 684
40. U. Savas, M.H. Hsu, K.J. Griffin, D.R. Bell, and E.F. Johnson Conditional regulation of the human CYP4X1 and CYP4Z1 genes Arch. Biochem. Biophys. 436 2005 377 385
41. M.A. Rieger, R. Ebner, D.R. Bell, A. Kiessling, J. Rohayem, M. Schmitz, A. Temme, E.P. Rieber, and B. Weigle Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma Cancer Res. 64 2004 2357 2364
42. D. Choudhary, I. Jansson, J.B. Schenkman, M. Sarfarazi, and I. Stoilov Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues Arch. Biochem. Biophys. 414 2003 91 100
43. S. Yamano, J. Tatsuno, and F.J. Gonzalez The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes Biochemistry 29 1990 1322 1329
44. A. Fersht Structure and Mechanism in Protein Science 1999 Freeman New York
45. F.P. Guengerich Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity Chem. Res. Toxicol. 14 2001 611 650
46. B.T. Hansen, S.W. Davey, A.J.L. Ham, and D.C. Liebler P-Mod: an algorithm and software to map modifications to peptide sequences from tandem MS data J. Proteome Res. 4 2005 358 368
47. I. Koch, R. Weil, R. Wolbold, J. Brockmoller, E. Hustert, O. Burk, A. Nuessler, P. Neuhaus, M. Eichelbaum, U. Zanger, and L. Wojnowski Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA Drug. Metab. Dispos. 30 2002 1108 1114